Global race for better kidney cancer treatment

NCT ID NCT07000149

Ongoing Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This large global study is testing whether new drug combinations work better than current standard treatment for advanced kidney cancer. The trial will involve over 1,100 patients who haven't received previous treatment for their advanced disease. Researchers are comparing two experimental approaches against the current standard combination therapy to see which helps patients live longer without their cancer worsening.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CLEAR CELL RENAL CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

La Jolla, California, 92037, United States
Research Site

Aurora, Colorado, 80045, United States
Research Site

Boston, Massachusetts, 02215, United States
Research Site

New York, New York, 10065, United States
Research Site

Cleveland, Ohio, 44106, United States
Research Site

Nashville, Tennessee, 37232, United States
Research Site

Lubbock, Texas, 79430, United States
Research Site

East Melbourne, 3002, Australia
Research Site

Elizabeth Vale, 5112, Australia
Research Site

North Adelaide, 5000, Australia
Research Site

Syndey, 4032, Australia
Research Site

Beijing, 100142, China
Research Site

Guangzhou, 510060, China
Research Site

Nanjing, 2100008, China
Research Site

Nanning, 530021, China
Research Site

Shanghai, 200032, China
Research Site

Xiamen, 361003, China
Research Site

Batumi, 6010, Georgia
Research Site

Tbilisi, 0112, Georgia
Research Site

Tbilisi, 0114, Georgia
Research Site

Tbilisi, 0186, Georgia
Research Site

Busan, 48108, South Korea
Research Site

Seongnam-si, 13496, South Korea
Research Site

Seongnam-si, 13620, South Korea
Research Site

Seoul, 03080, South Korea
Research Site

Seoul, 03722, South Korea
Research Site

Seoul, 06591, South Korea
Research Site

Seoul, 5505, South Korea
Research Site

Kaohsiung City, 833401, Taiwan
Research Site

Taichung, 404327, Taiwan
Research Site

Taichung, 40705, Taiwan
Research Site

Tainan, 704, Taiwan

Conditions

Explore the condition pages connected to this study.

ADVANCED CLEAR CELL RENAL CELL CARCINOMA